Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1969 Aug 16;3(5667):387-9.
doi: 10.1136/bmj.3.5667.387.

Fibrinolytic enzyme system and pregnancy

Fibrinolytic enzyme system and pregnancy

J Bonnar et al. Br Med J. .

Abstract

The effect of pregnancy on the components of the fibrinolytic enzyme system was determined by serial observations on 10 healthy women during normal pregnancy, labour, and the puerperium. The plasminogen level was substantially increased in the third trimester; the increase occurred pari passu with a pronounced increase in fibrinogen concentration. After allowing for the expansion of plasma volume in pregnancy a twofold increase in the absolute amounts of circulating fibrinogen and plasminogen was found. In late pregnancy and during labour the level of plasminogen activator was greatly decreased, whereas a normal or increased level was present in the first week of the puerperium. No alteration in the levels of inhibitors of plasminogen activation by urokinase was found during normal pregnancy. The thrombin time and platelet count remained unchanged during pregnancy and labour but the platelet count rose significantly during the first week of the puerperium.The haemostatic mechanism in pregnancy appears to be altered towards an enhanced capacity to form fibrin and a diminished ability to lyse fibrin. These changes may be a physiological development to ensure the integrity of the foetal and maternal circulations and provide rapid and effective haemostasis in the uterus during and after placental separation. Nevertheless, the changes may also establish a vulnerable state for intravascular fibrin deposition.

PubMed Disclaimer

References

    1. Am J Obstet Gynecol. 1966 Jan 1;94(1):14-20 - PubMed
    1. Am J Obstet Gynecol. 1964 Sep 1;90:44-50 - PubMed
    1. Clin Chim Acta. 1965 May;11:414-23 - PubMed
    1. Acta Obstet Gynecol Scand. 1967;46(3):273-85 - PubMed
    1. J Clin Pathol. 1967 Mar;20(2):209-11 - PubMed

LinkOut - more resources